A 18-Year Study of Thyroid Cancer Mortality, A Retrospective Single Centre Study in Saudi Based Community Hospital

Khalid S. Aljabri, MD, FRCPC, FACP^1*, Samia A. Bokhari, MD, SBEM¹, Muneera A. Alshareef, MD, SBIM¹, Patan M. Khan, MD, MRCP¹, Hesham M. AbuElsaoud, MD¹, Mohammad M. Jalal, MD¹, Rania F. Safwat, MD¹, Rehab El Boraie, MD¹, Nawaf K. Aljabri, MLT² & Bandari K. Aljabri, MS³

¹Department of Endocrinology, King Fahad Armed Forces Hospital, Jeddah, Kingdom of Saudi Arabia
²Department of Laboratory, Northern Armed Forces Hospital, Hafr Al-Batin, Kingdom of Saudi Arabia
³College of Medicine, Um Al Qura University, Makkah, Kingdom of Saudi Arabia

Dr. Khalid S. Aljabri, MD, FRCPC, FACP, Department of Endocrinology, King Fahad Armed Forces Hospital, Jeddah, Kingdom of Saudi Arabia.

Keywords: Thyroid Cancers; Mortality; Saudi Arabia

Abstract

Background
Thyroid carcinoma (TC) is the second most common malignancy in Saudi Arabia. We describe and interpret trends in the frequency of TC mortality in Saudi population during the 2000-2017 period.
Methods
Retrospective study of TC received at the department of pathology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia from January 2000 to December 2017

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).